Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
|---|---|---|---|---|---|
| 1 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 2 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 3 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 4 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 5 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 6 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 7 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 8 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 9 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 10 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 11 | Cadherin signaling 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 12 | Cadherin signaling 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 13 | Cadherin signaling 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 14 | Cadherin signaling 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 15 | Cadherin signaling 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 16 | Calcium signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 17 | Calcium signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 18 | Calcium signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 19 | Calcium signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 20 | Calcium signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 21 | Central carbon metabolism in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 22 | Central carbon metabolism in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 23 | Central carbon metabolism in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 24 | Central carbon metabolism in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 25 | Central carbon metabolism in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 26 | IgSF CAM signaling 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 27 | IgSF CAM signaling 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 28 | IgSF CAM signaling 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 29 | IgSF CAM signaling 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 30 | IgSF CAM signaling 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 31 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 32 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 33 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 34 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 35 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 36 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 37 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 38 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 39 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 40 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 41 | Parathyroid hormone synthesis, secretion and action 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 42 | Parathyroid hormone synthesis, secretion and action 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 43 | Parathyroid hormone synthesis, secretion and action 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 44 | Parathyroid hormone synthesis, secretion and action 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 45 | Parathyroid hormone synthesis, secretion and action 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 46 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 47 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 48 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 49 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 50 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 51 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 52 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 53 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 54 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 55 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 56 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 57 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 58 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 59 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 60 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 61 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 62 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 63 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 64 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 65 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 66 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 67 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 68 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 69 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 70 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 71 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 72 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 73 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 74 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 75 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 76 | Regulation of actin cytoskeleton 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 77 | Regulation of actin cytoskeleton 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 78 | Regulation of actin cytoskeleton 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 79 | Regulation of actin cytoskeleton 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 80 | Regulation of actin cytoskeleton 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 81 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 82 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 83 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 84 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 85 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 86 | Thermogenesis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Catequentinib Catequentinib 💬
| Anlotinib | 085 [1] 85 💬
|
| 87 | Thermogenesis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib Infigratinib 💬
| Infigratinib | 276 [1] 276 💬
|
| 88 | Thermogenesis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Infigratinib phosphate Infigratinib phosphate 💬
| Infigratinib | 276 [1] 276 💬
|
| 89 | Thermogenesis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib esylate Nintedanib esylate 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
| 90 | Thermogenesis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
FGFR1 [1] FGFR1 💬
|
Nintedanib Nintedanib 💬
| Nintedanib | 051 [7] 51, 84, 85, 89, 227, 228, 331 💬
|
